The Claim

Among suspicious lesions detected by whole-body MRI in asymptomatic TP53 carriers, 18% (95% CI: 0.13–0.25) are confirmed as cancer, indicating a moderate positive predictive value for lesion-based detection.

Source: Baseline surveillance in Li Fraumeni syndrome using whole-body MRI: a systematic review and updated meta-analysis

What the research says

Supports is higher

Support is ahead, but a single strong opposing study can change this.

Supports
42score
Challenges
0score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

Quantitative
1 study reviewed
In plain English

When doctors scan people with a rare gene mutation (TP53) who feel fine, and they find weird spots on the scan, about 18% of those spots turn out to be real cancer — so the scan is somewhat helpful but not perfect at catching cancer early.

See the scientific wording

Among suspicious lesions detected by whole-body MRI in asymptomatic TP53 carriers, 18% (95% CI: 0.13–0.25) are confirmed as cancer, indicating a moderate positive predictive value for lesion-based detection.

What the research says

1 study
  1. Study: Baseline surveillance in Li Fraumeni syndrome using whole-body MRI: a systematic review and updated meta-analysis

    This study checked if MRI scans can find early cancers in people with a high cancer risk gene (TP53), and found that about 18% of weird spots on the scans turned out to be real cancers — just like the claim said.

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.